Mont-Royal, Canada

Krishna Raj Tiwari

This inventor holds 1 USPTO granted patent. Top assignee: Oncolytics Biotech Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Krishna Raj Tiwari. Retrieved from https://idiyas.com/inventor/krishna-raj-tiwari

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Krishna Raj Tiwari

Introduction

Krishna Raj Tiwari is a notable inventor based in Mont-Royal, Canada. He has made significant contributions to the field of biotechnology, particularly in viral extraction techniques. His work is essential for advancing research in medical and therapeutic applications.

Latest Patents

Krishna Raj Tiwari holds a patent for "Viral Extraction from Cell Culture." This innovative method enhances the efficiency of isolating viruses from cell cultures, which is crucial for various research and clinical applications. He has 1 patent to his name, showcasing his expertise in this specialized area.

Career Highlights

Tiwari is currently employed at Oncolytics Biotech Inc., a company dedicated to developing innovative cancer therapies. His role at the company allows him to apply his knowledge and skills in a practical setting, contributing to groundbreaking advancements in cancer treatment.

Collaborations

Throughout his career, Tiwari has worked alongside talented colleagues, including Allison Hagerman and Jyoti Latawa. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Krishna Raj Tiwari's contributions to biotechnology, particularly in viral extraction, highlight his role as an influential inventor. His work at Oncolytics Biotech Inc. and his collaborations with esteemed colleagues further emphasize his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…